Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeNon-cash ItemsOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Incannex Healthcare (IXHL) Depreciation and Depletion (2023 - 2025)

Incannex Healthcare's Depreciation and Depletion history spans 3 years, with the latest figure at -$65.9 million for Q4 2025.

  • For Q4 2025, Depreciation and Depletion fell 33050.0% year-over-year to -$65.9 million; the TTM value through Dec 2025 reached $143.0 billion, up 38.76%, while the annual FY2025 figure was $143.0 billion, 38.83% up from the prior year.
  • Depreciation and Depletion for Q4 2025 was -$65.9 million at Incannex Healthcare, down from $66.0 million in the prior quarter.
  • Across five years, Depreciation and Depletion topped out at $143.0 billion in Q2 2025 and bottomed at -$65.9 million in Q4 2025.
  • The 3-year median for Depreciation and Depletion is $6.1 million (2023), against an average of $24.6 billion.
  • The largest annual shift saw Depreciation and Depletion surged 700.0% in 2024 before it crashed 33050.0% in 2025.
  • A 3-year view of Depreciation and Depletion shows it stood at $25000.0 in 2023, then soared by 700.0% to $200000.0 in 2024, then plummeted by 33050.0% to -$65.9 million in 2025.
  • Per Business Quant, the three most recent readings for IXHL's Depreciation and Depletion are -$65.9 million (Q4 2025), $66.0 million (Q3 2025), and $143.0 billion (Q2 2025).